Amrize (AMRZ) EPS (Weighted Average and Diluted) (2024 - 2026)

Amrize has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting -$0.21 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.21, down 31.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.09 (down 5.86% YoY), and the FY2025 annual result was $2.14, down 6.96% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.21 for Q1 2026 at Amrize, down from $0.54 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.0 in Q3 2024 to a low of -$0.21 in Q1 2026.
• The 3-year median for EPS (Weighted Average and Diluted) is $0.66 (2025), against an average of $0.54.
• Across the five-year window, EPS (Weighted Average and Diluted) rose 3.85% in 2025 and slumped 31.25% in 2026, its largest moves.
• Amrize's EPS (Weighted Average and Diluted) stood at $0.52 in 2024, then advanced by 3.85% to $0.54 in 2025, then plunged by 138.89% to -$0.21 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.21 (Q1 2026), $0.54 (Q4 2025), and $0.98 (Q3 2025), per Business Quant data.